XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 60 filers reported holding XENON PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,229 | -27.0% | 2,495 | -17.8% | 0.00% | – |
| Q2 2023 | $116,810 | +30.8% | 3,034 | +21.6% | 0.00% | – |
| Q1 2023 | $89,296 | -9.2% | 2,495 | 0.0% | 0.00% | – |
| Q4 2022 | $98,378 | -19.4% | 2,495 | -68.8% | 0.00% | – |
| Q3 2021 | $122,000 | +12100.0% | 7,987 | +14969.8% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 53 | -39.8% | 0.00% | – |
| Q1 2021 | $2,000 | -99.6% | 88 | -99.7% | 0.00% | – |
| Q4 2020 | $470,000 | +39.5% | 30,520 | +0.2% | 0.00% | – |
| Q3 2020 | $337,000 | -11.8% | 30,469 | 0.0% | 0.00% | – |
| Q2 2020 | $382,000 | -64.6% | 30,469 | -68.0% | 0.00% | -100.0% |
| Q1 2020 | $1,078,000 | +2529.3% | 95,080 | +2933.8% | 0.00% | – |
| Q4 2019 | $41,000 | +115.8% | 3,134 | +53.1% | 0.00% | – |
| Q2 2019 | $19,000 | -48.6% | 2,047 | -45.6% | 0.00% | – |
| Q1 2019 | $37,000 | -92.0% | 3,766 | -94.9% | 0.00% | – |
| Q4 2018 | $461,000 | -66.7% | 73,200 | -30.2% | 0.00% | – |
| Q3 2018 | $1,383,000 | -38.0% | 104,846 | -56.8% | 0.00% | -100.0% |
| Q2 2018 | $2,230,000 | +9191.7% | 242,446 | +2680.7% | 0.00% | – |
| Q4 2017 | $24,000 | -92.6% | 8,719 | -92.0% | 0.00% | – |
| Q3 2017 | $323,000 | +878.8% | 109,559 | +923.9% | 0.00% | – |
| Q2 2017 | $33,000 | -34.0% | 10,700 | -16.0% | 0.00% | – |
| Q1 2017 | $50,000 | -49.0% | 12,737 | -0.2% | 0.00% | – |
| Q4 2016 | $98,000 | -57.8% | 12,762 | -55.6% | 0.00% | – |
| Q3 2016 | $232,000 | +1004.8% | 28,748 | +688.5% | 0.00% | – |
| Q2 2016 | $21,000 | -60.4% | 3,646 | -52.1% | 0.00% | – |
| Q1 2016 | $53,000 | -13.1% | 7,616 | -0.4% | 0.00% | – |
| Q4 2015 | $61,000 | -37.8% | 7,647 | -35.7% | 0.00% | – |
| Q3 2015 | $98,000 | -59.7% | 11,885 | -43.7% | 0.00% | – |
| Q2 2015 | $243,000 | – | 21,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |